Moreover, studies in Arua District report that 15 per cent of patients are not responding to eflornithine, as well as there being 30 per cent resistance to melarsoprol.
Moreover, studies in Arua District report that 15 per cent of patients are not responding to eflornithine, as well as there being 30 per cent resistance to melarsoprol.